Localized scleroderma

Common Name(s)

Localized scleroderma

Localized scleroderma is characterized by thickening of the skin from excessive collagen deposits. Collagen is a protein normally present in our skin that provides structural support. However, when too much collagen is made, the skin becomes stiff and hard. Localized types of scleroderma are those limited to the skin and related tissues and, in some cases, the muscle below. Internal organs are not affected by localized scleroderma, and localized scleroderma can never progress to the systemic form of the disease. Often, localized conditions improve or go away on their own over time, but the skin changes and damage that occur when the disease is active can be permanent. For some people, localized scleroderma is serious and disabling.

There are two generally recognized types of localized scleroderma: morphea and linear.

 

 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Localized scleroderma" for support, advocacy or research.

Logo
Raynaud's & Scleroderma Ireland

• To improve the lives of patients, their families and carers by providing support, advice and information. • To increase the awareness of Raynaud’s and Scleroderma amongst healthcare professionals, Government and Statutory agencies and the general public. • To work in partnership with appropriate healthcare professionals and agencies to promote and co-ordinate the attainment of the objectives of the strategy. • Maintain a working environment that fosters communication, teamwork and diversity among all members of staff- permanent, temporary and voluntary

Last Updated: 6 May 2014

View Details

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Localized scleroderma" for support, advocacy or research.

Logo
Raynaud's & Scleroderma Ireland

• To improve the lives of patients, their families and carers by providing support, advice and information. • To increase the awareness of Raynaud’s and Scleroderma amongst healthcare professionals, Government and Statutory agencies and the general public. • To work in partnership with appropriate healthcare professionals and agencies to promote and co-ordinate the attainment of the objectives of the strategy. • Maintain a working environment that fosters communication, teamwork and diversity among all members of staff- permanent, temporary and voluntary

http://www.irishraynauds.com

Last Updated: 6 May 2014

View Details

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Localized scleroderma" returned 50 free, full-text research articles on human participants. First 3 results:

Lichen sclerosus associated with localized scleroderma: dermoscopy contribution.
 

Author(s): Monisa Martins Nóbrega, Fernanda Cabral, Mariana César Corrêa, Carlos Baptista Barcaui, Aline Lopes Bressan, Alexandre Carlos Gripp

Journal: An Bras Dermatol. ;91(4):534-6.

 

Lichen sclerosus is an uncommon inflammatory dermatosis with preferential involvement of the urogenital region. The extragenital involvement is uncommon and is characterized by small rounded macules or papules, pearly white in color. The coexistence of lichen sclerosus and scleroderma ...

Last Updated: 1 Sep 2016

Go To URL
Drug Survival and Predictors of Drug Survival for Methotrexate Treatment in a Retrospective Cohort of Adult Patients with Localized Scleroderma.
 

Author(s): Jorre S Mertens, Juul M van den Reek, Wietske Kievit, Peter C M van de Kerkhof, Rogier M Thurlings, Tim R D Radstake, Marieke M B Seyger, Elke M G J de Jong

Journal: Acta Derm. Venereol.. 2016 Nov;96(7):943-947.

 

Data regarding the efficacy and safety of methotrexate (MTX) in adults with localized scleroderma (LoS) is scarce. This study gathered data from a retrospective cohort of adult patients with LoS (n?=?107), treated with MTX (1993-2015). MTX drug survival and predictors thereof were ...

Last Updated: 11 May 2016

Go To URL
Use of Mycophenolate Mofetil in Patients with Severe Localized Scleroderma Resistant or Intolerant to Methotrexate.
 

Author(s): Jorre S Mertens, Diane Marsman, Peter C M van de Kerkhof, Esther P A H Hoppenreijs, Hanneke K A Knaapen, Timothy R D Radstake, Elke M G J de Jong, Marieke M B Seyger

Journal: Acta Derm. Venereol.. 2016 May;96(4):510-3.

 

To assess the efficacy and safety of mycophenolate mofetil (MMF) in patients with localized scleroderma (LoS) resistant or intolerant to previous treatment with methotrexate (MTX). A case series of patients with LoS treated with MMF. Outcome was assessed through clinical examination. ...

Last Updated: 12 Apr 2016

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Localized scleroderma" returned 7 free, full-text review articles on human participants. First 3 results:

Localized scleroderma presenting as port-wine stains: report of two cases and a literature review.
 

Author(s): Hiroyuki Kanoh, En Shu, Yoshiro Ichiki, Mariko Seishima

Journal: Acta Derm. Venereol.. 2015 Nov;95(8):1003-4.

 

Last Updated: 4 Nov 2015

Go To URL
Localized scleroderma: clinical spectrum and therapeutic update.
 

Author(s): Mariana Figueiroa Careta, Ricardo Romiti

Journal: An Bras Dermatol. ;90(1):62-73.

 

Scleroderma is a rare connective tissue disease that is manifested by cutaneous sclerosis and variable systemic involvement. Two categories of scleroderma are known: systemic sclerosis, characterized by cutaneous sclerosis and visceral involvement, and localized scleroderma or morphea ...

Last Updated: 12 Feb 2015

Go To URL
Pediatric scleroderma: systemic or localized forms.
 

Author(s): Kathryn S Torok

Journal: Pediatr. Clin. North Am.. 2012 Apr;59(2):381-405.

 

Pediatric scleroderma includes 2 major groups of clinical entities, systemic sclerosis (SSc) and localized scleroderma (LS). Although both share a common pathophysiology, their clinical manifestations differ. LS is typically confined to the skin and underlying subcutis, with up to ...

Last Updated: 7 May 2012

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Genetic Variants in Linear Localized Scleroderma
 

Status: Recruiting

Condition Summary: Morphea

 

Last Updated: 4 Feb 2016

Go to URL
Morphea in Adults and Children (MAC) Cohort Study: A Morphea Registry and DNA Repository
 

Status: Recruiting

Condition Summary: Scleroderma, Localized; Morphea; Frontal Linear Scleroderma en Coup de Sabre; Scleroderma, Circumscribed; Scleroderma, Linear

 

Last Updated: 2 Dec 2014

Go to URL
Scleroderma Registry & Repository at the Hospital for Special Surgery
 

Status: Recruiting

Condition Summary: Scleroderma

 

Last Updated: 13 Mar 2017

Go to URL